Por favor, use este identificador para citar o enlazar este ítem:
https://www.arca.fiocruz.br/handle/icict/686
Tipo
ArtículoDerechos de autor
Acceso abierto
Colecciones
Metadatos
Mostrar el registro completo del ítem
INJECTING DRUG USERS WHO ARE (UN)AWARE OF THEIR HIV SEROSTATUS: FINDINGS FROM THE MULTI-CENTER STUDY AJUDE-BRASIL II
Infecções por HIV
Síndrome de Imunodeficiência Adquirida
Sorodiagnóstico da AIDS
HIV
Titulo alternativo
Usuários de drogas injetáveis que (des)conhecem seu status sorológico para a infecção pelo HIV: achados do Projeto AjUDE-Brasil IIAutor
Afiliación
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Instituto de Ciências Exatas. Belo Horizonte, MG, Brasil.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Centro de Informação Científica e Tecnológica. Rio de Janeiro, RJ, Brasil.
Universidade Federal de Minas Gerais. Instituto de Ciências Exatas. Belo Horizonte, MG, Brasil.
Resumen en portugues
This study aimed to characterize the profiles of injecting drug users (IDUs) who were unaware of their HIV serostatus, given the importance of this information for prevention strategies, especially in this vulnerable population, key to the HIV/AIDS dynamic. As part of a cross-sectional multi-city survey, IDUs were interviewed and HIV-tested by the ELISA technique. IDUs were categorized according to knowledge of their own
HIV status as either aware or unaware.Means,
averages, and proportions were compared between the groups using bi- and multivariate
analyses. Of 857 IDUs interviewed, 34.2% were
unaware of their HIV serostatus. Those who were unaware were more likely: to have been recruited at sites where the HIV prevalence rate was considered medium (> 10 to 50%; odds ratio = 8.0) or high (> 50%; 4.0); to be illiterate (OR = 4.54); to have no prior HIV test (OR = 2.22); to be male (OR = 1.81); and to have been enrolled more recently in syringe-exchange programs (OR = 1.69). HIV prevention programs should target both individuals at risk and HIV-positive
individuals. Programs to expand access to HIV
testing are pivotal and should be tailored to specific contexts and populations.
DeCS
Abuso de substâncias por via intravenosaInfecções por HIV
Síndrome de Imunodeficiência Adquirida
Sorodiagnóstico da AIDS
HIV
Compartir